Kalpataru Multiplier Ltd.

Our Bank & DP Click for Online Payment MF portfolio login smart way to invest in gold
Sovereign gold bond(SGB) Exchange trades funds(ETF)
CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

Company Profile
more from company profile
HomeMarkets Company Profile Smart Quotes

Smart Quotes

DIVI'S LABORATORIES LTD.

NSE : DIVISLABBSE : 532488ISIN CODE : INE361B01024Industry : Pharmaceuticals & DrugsHouse : Divis Labs
BSE6474.50301.8 (+4.89 %)
PREV CLOSE () 6172.70
OPEN PRICE () 6233.70
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 51042
TODAY'S LOW / HIGH ()6121.10 6775.80
52 WK LOW / HIGH ()4941.7 7077.7
NSE6386.50211 (+3.42 %)
PREV CLOSE() 6175.50
OPEN PRICE () 6194.00
BID PRICE (QTY) 6386.50 (38)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1263189
TODAY'S LOW / HIGH() 6126.00 6793.00
52 WK LOW / HIGH ()4955 7071.5
BSE NSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1990

Management Info :

Ramesh BV Nimmagadda - Chairman Murali K Divi - Managing Director

Registered Office :

Address : 1-72/23( P)/ Divis/303,Divi Towers, Cyber Hills,Gachibowli,
Hyderabad,
Telangana-500032

Phone : 040 66966300 / 400

Website : www.divislabs.com

Registrar's Details : K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE
NEWS
30Jan Divis Laboratories informs about board
Divis Laboratories has informed that the meeting of the Board of Directo..
03Jan Divi's Laboratories informs about cert
Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Reg..
31Dec Divi’s Laboratories informs about clos
Pursuant to the Company’s Code of Conduct to Regulate, Monitor and Repor..
10Nov Divi's Laboratories reports 35% rise i
Divi's Laboratories has reported result for second quarter ended Septemb..
12Aug Divi's Laboratories informs about tran
Divi's Laboratories has submitted the transcript of the earnings confere..
Financials
in Millions
QTR Dec 25 ANNUAL 25
Net Profit598022090
Gross Profit 7980 29290
Operating Profit 994033310
Net Sales 2578091980
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Pfizer (BSE)
 5201.35 (4.76%)
M.Cap ( in Cr)
23795.00
Astrazeneca Pharma I (BSE)
 9070.80 (1.30%)
M.Cap ( in Cr)
22677.00
Fredun Pharma (BSE)
 1882.50 (5.59%)
M.Cap ( in Cr)
1010.15
Glaxosmithkline Phar (BSE)
 2700.80 (3.09%)
M.Cap ( in Cr)
45753.18
Alkem Laboratories (BSE)
 5887.85 (1.28%)
M.Cap ( in Cr)
70398.08
Shareholding Pattern
PROMOTERS 51.88%
MUTUAL FUNDS/UTI 13.73%
NON-INSTITUTION 8.76%
FI/BANKS/INSURANCE 4.96%
GOVERNMENT 0%
FII 0%
Mf Holding
ATTENTION INVESTORS

Kalpataru Multiplier Ltd.

Kalpataru is a wishful Divine Tree and in present context a widely Trusted, Time tested and Transparent Share Broker, Mutual Fund Distributor and D.P. of this region.

Mobile Trading App
Mobile Trading IOS App
Call Us 0755-4350141/142/143, 9425008895
Mutual Funds 0755-4276725, 4276726
Email Uskmlho@kalpatarumulti.com

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
SENSEX84233.64-40.28 (-0.05%)
NIFTY25953.8518.70 (0.07%)
Dow Jones 50188.1452.27 (0.10%)
Nasdaq 23102.47-136.20 (-0.59%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI